Benlier and coworkers showed that HMGB1 levels were higher in patients with CAD, compared with healthy individuals, suggesting that HMGB1 was an independent risk factor for the disease; however, in this study 62% of patients with CAD were affected by T2DM [66]. Here, HMGB1 is linked to type 2 diabetes mellitus.